Entrada Therapeutics Other Current Assets

Entrada Therapeutics (TRDA) currently reports a other current assets of $12M as of March 2026. That compares with $19M in the prior-year period — down 35.5% year over year. Use the charts on this page to explore Entrada Therapeutics's other current assets history and peer comparisons.

Entrada Therapeutics's other current assets decreased from $19M to $12M — a 35.5% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Entrada Therapeutics reported $12M in other current assets as of March 2026. That compares with $19M in the prior-year period — down 35.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $12M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Entrada Therapeutics, and consider following TRDA for alerts when major investors trade the stock.